This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

David J. Wyler, MD

JAMA. 1984;251(18):2420-2422.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The article by Harry Most and colleagues in a 1946 issue of THE JOURNAL was the first report in the American medical literature on the efficacy of chloroquine (a 4-aminoquinoline) as an antimalarial agent in humans. This study of roughly 300 military personnel who had acquired vivax malaria during World War II demonstrated the superiority of chloroquine over quinacrine (the only synthetic antimalarial compound used clinically at that time) and quinine (an active alkyloid present in cinchona bark extracts, which were used for centuries). The report represented a milestone on the long and winding road toward a highly efficacious and relatively nontoxic synthetic antimalarial agent (reviewed in detail in reference 1) and began a period of about three decades during which the drug served an important role in malaria control programs in endemic areas.

Unfortunately, the days of chloroquine's greatest glory were numbered. In 1961, the first report² of . . . [Full Text PDF of this Article]

Author Affiliations
From the Division of Geographic Medicine, Department of Medicine, Tufts University School of Medicine, Boston.

Footnotes
Reprint requests to Division of Geographic Medicine, Tufts University School of Medicine, 136 Harrison Ave, Boston, MA 02111 (Dr Wyler).

A commentary on Most H, London IM, Kane CA, et al: Chloroquine for treatment of acute attacks of vivax malaria. JAMA 1946;131:963-967.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?